Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L. McCoy, … , Alana L. Welm, Heide L. Ford
Erica L. McCoy, … , Alana L. Welm, Heide L. Ford
Published August 24, 2009
Citation Information: J Clin Invest. 2009;119(9):2663-2677. https://doi.org/10.1172/JCI37691.
View: Text | PDF
Research Article Article has an altmetric score of 1

Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition

  • Text
  • PDF
Abstract

Six1 is a developmentally regulated homeoprotein with limited expression in most normal adult tissues and frequent misexpression in a variety of malignancies. Here we demonstrate, using a bitransgenic mouse model, that misexpression of human Six1 in adult mouse mammary gland epithelium induces tumors of multiple histological subtypes in a dose-dependent manner. The neoplastic lesions induced by Six1 had an in situ origin, showed diverse differentiation, and exhibited progression to aggressive malignant neoplasms, as is often observed in human carcinoma of the breast. Strikingly, the vast majority of Six1-induced tumors underwent an epithelial-mesenchymal transition (EMT) and expressed multiple targets of activated Wnt signaling, including cyclin D1. Interestingly, Six1 and cyclin D1 coexpression was found to frequently occur in human breast cancers and was strongly predictive of poor prognosis. We further show that Six1 promoted a stem/progenitor cell phenotype in the mouse mammary gland and in Six1-driven mammary tumors. Our data thus provide genetic evidence for a potent oncogenic role for Six1 in mammary epithelial neoplasia, including promotion of EMT and stem cell–like features.

Authors

Erica L. McCoy, Ritsuko Iwanaga, Paul Jedlicka, Nee-Shamo Abbey, Lewis A. Chodosh, Karen A. Heichman, Alana L. Welm, Heide L. Ford

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 5 4 5 4 8 3 2 6 4 9 10 7 11 6 9 1 94
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (95)

Title and authors Publication Year
Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells
Kulus M, Farzaneh M, Bryja A, Zehtabi M, Azizidoost S, Abouali Gale Dari M, Golcar-Narenji A, Ziemak H, Chwarzyński M, Piotrowska\u2013Kempisty H, Dzięgiel P, Zabel M, Mozdziak P, Bukowska D, Kempisty B, Antosik P
Stem Cell Reviews and Reports 2024
Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
Wareing N, Mills TW, Collum S, Wu M, Revercomb L, Girard R, Lyons M, Skaug B, Bi W, Ali MA, Koochak H, Flores AR, Yang Y, Zheng WJ, Swindell W, Assassi S, Karmouty-Quintana H
2024
Biochemical characterization of the Eya and PP2A-B55α interaction.
Alderman C, Anderson R, Zhang L, Hughes CJ, Li X, Ebmeier C, Wagley ME, Ahn NG, Ford HL, Zhao R
The Journal of biological chemistry 2024
Lack of basic rationale in epithelial-mesenchymal transition and its related concepts
Cao Y
Cell & Bioscience 2024
Cytoplasmatic Localization of Six1 in Male Testis and Spermatogonial Stem Cells
Qin M, Ma L, Du W, Chen D, Luo G, Liu Z
International Journal of Stem Cells 2024
Retinal determination gene networks: from biological functions to therapeutic strategies
Zhu S, Li W, Zhang H, Yan Y, Mei Q, Wu K
Biomarker Research 2023
The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation.
Haerinck J, Goossens S, Berx G
Nature reviews. Genetics 2023
Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective
VARISLI L, TOLAN V, CEN JH, VLAHOPOULOS S, CEN O
Oncology research 2023
SIX1 amplification modulates stemness and tumorigenesis in breast cancer
Guo L, Li F, Liu H, Kong D, Chen C, Sun S
Journal of Translational Medicine 2023
Sine Oculis Homeobox Homolog 1 (Six1) Plays a Critical Role in Pulmonary Fibrosis
Cory Wilson, Tinne C.J. Mertens, Pooja Shivshankar, Weizen Bi, Scott Collum, Nancy Wareing, Junsuk Ko, Tingting Mills, Ram P Naikawadi, Paul Wolters, Pascal Maire, Soma Jyothula, Rajarajan Thandavarayan, Dewei Ren, Nathan D Elrod, Eric J Wagner, Howard J. Huang, Burton Dickey, Heide L. Ford, Harry Karmouty-Quintana
JCI Insight 2022
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
M Migault, S Sapkota, C Bracken
Cellular and Molecular Life Sciences 2022
Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers
Tarek A, El-Sayed SK, Woodward WA, El-Shinawi M, Hirshon JM, Mohamed MM
Current issues in molecular biology 2022
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state
Hsu JY, Danis EP, Nance S, O\u2019Brien JH, Gustafson AL, Wessells VM, Goodspeed AE, Talbot JC, Amacher SL, Jedlicka P, Black JC, Costello JC, Durbin AD, Artinger KB, Ford HL
Cell Reports 2022
Ecdysoneless overexpression drives mammary tumorigenesis through upregulation of c-MYC and glucose metabolism
Mohapatra BC, Mirza S, Bele A, Gurumurthy CB, Raza M, Saleem I, Storck MD, Sarkar A, Kolala SS, Shukla SK, Southekal S, Wagner KU, Qiu F, Lele SM, Alsaleem MA, Rakha EA, Guda C, Singh PK, Cardiff RD, Band H, Band V
Molecular cancer research : MCR 2022
SIX1 Activation Is Involved in Cell Proliferation, Migration, and Anti-inflammation of Acute Ischemia/Reperfusion Injury in Mice
Y Jin, M Zhang, M Li, H Zhang, L Zhao, C Qian, S Li, H Zhang, M Gao, B Pan, R Li, X Wan, C Cao
Frontiers in Molecular Biosciences 2021
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
L Bornes, G Belthier, J van Rheenen
Journal of Clinical Medicine 2021
The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology
L Meurer, L Ferdman, B Belcher, T Camarata
Frontiers in Cell and Developmental Biology 2021
An EMT–primary cilium–GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis
MM Wilson, C Callens, ML Gallo, S Mironov, Q Ding, A Salamagnon, TE Chavarria, R Viel, AD Peasah, A Bhutkar, S Martin, F Godey, P Tas, HS Kang, PP Juin, AM Jetten, JE Visvader, RA Weinberg, M Attanasio, C Prigent, JA Lees, VJ Guen
Science Advances 2021
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Á Quintanal-Villalonga, JM Chan, HA Yu, D Peer, CL Sawyers, S Triparna, CM Rudin
Nature Reviews Clinical Oncology 2020
Increased SIX-1 expression promotes breast cancer metastasis by regulating lncATB-miR-200s-ZEB1 axis
L Zhu, S Jiang, S Yu, X Liu, S Pu, P Xie, H Chen, X Liao, K Wang, B Wang
Journal of Cellular and Molecular Medicine 2020
Cellular Plasticity in Breast Cancer Progression and Therapy
D Kong, CJ Hughes, HL Ford
Frontiers in Molecular Biosciences 2020
Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming
X Lai, Q Li, F Wu, J Lin, J Chen, H Zheng, L Guo
Frontiers in Cell and Developmental Biology 2020
SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET
Q He, Z Lin, Z Wang, W Huang, D Tian, M Liu, L Xia
Oncogene 2020
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
CR Schmidt, NJ Achille, A Kuntimaddi, AM Boulton, BI Leach, S Zhang, NJ Zeleznik-Le, JH Bushweller
2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis
H Zhou, MA Blevins, JY Hsu, D Kong, MD Galbraith, A Goodspeed, R Culp-Hill, MU Oliphant, D Ramirez, L Zhang, J Trinidad-Pineiro, LM Griner, R King, E Barnaeva, X Hu, NT Southall, M Ferrer, DL Gustafson, DP Regan, A D'Alessandro, JC Costello, S Patnaik, J Marugan, R Zhao, HL Ford
Cancer research 2020
Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6
M Jin, D Gao, R Wang, A Sik, K Liu
Oncology reports 2020
Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
CD Savci-Heijink, H Halfwerk, GK Hooijer, J Koster, HM Horlings, SL Meijer, MJ van de Vijver
Breast Cancer Research and Treatment 2019
SIX1 represses senescence and promotes SOX2-mediated cellular plasticity during tumorigenesis
CD Lope, S Martín-Alonso, J Auzmendi-Iriarte, C Escudero, I Mulet, J Larrasa-Alonso, I López-Antona, A Matheu, I Palmero
Scientific Reports 2019
A NIK–SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB
Z Liu, KB Mar, NW Hanners, SS Perelman, M Kanchwala, C Xing, JW Schoggins, NM Alto
Nature 2019
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation
Rebecca Vartuli, Hengbo Zhou, Lingdi Zhang, Rani Powers, Jared Klarquist, Pratyaydipta Rudra, Melanie Vincent, Debashis Ghosh, James Costello, Ross M Kedl, Jill Slansky, Rui Zhao, Heide Ford
Journal of Clinical Investigation 2018
miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression
Y Chu, M Jiang, F Du, D Chen, T Ye, B Xu, X Li, W Wang, Z Qiu, H Liu, Y Nie, J Liang, D Fan
FEBS Open Bio 2018
Alteration of Mammary Gland Development and Gene Expression by In Utero Exposure to Cadmium
D Parodi, M Greenfield, C Evans, A Chichura, A Alpaugh, J Williams, K Cyrus, M Martin
International journal of molecular sciences 2017
EMT/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids
E Forte, I Chimenti, P Rosa, F Angelini, F Pagano, A Calogero, A Giacomello, E Messina
Cancers 2017
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
MH Meel, SA Schaper, GJ Kaspers, E Hulleman
Cellular and Molecular Life Sciences 2017
Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies
N Sun, A Taguchi, S Hanash
Journal of Clinical Medicine 2016
Roles and epigenetic regulation of epithelial–mesenchymal transition and its transcription factors in cancer initiation and progression
JY Lee, G Kong
Cellular and Molecular Life Sciences 2016
The retinal determination gene network: from developmental regulator to cancer therapeutic target
D Kong, Y Liu, Q Liu, N Han, C Zhang, RG Pestell, K Wu, G Wu
Oncotarget 2016
Epithelial to endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors
B Sun, D Zhang, N Zhao, X Zhao
Oncotarget 2015
The SIX1-EYA transcriptional complex as a therapeutic target in cancer
MA Blevins, CG Towers, AN Patrick, R Zhao, HL Ford
Expert Opinion on Therapeutic Targets 2015
Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity
O Filhol, S Giacosa, Y Wallez, C Cochet
Cellular and Molecular Life Sciences 2015
SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis
P Nikpour, E Emadi-Andani, M Emadi-Baygi
Advanced Biomedical Research 2015
MiR-204-5p/Six1 feedback loop promotes epithelial–mesenchymal transition in breast cancer
J Zeng, M Wei, R Shi, C Cai, X Liu, T Li, W Ma
Tumor Biology 2015
The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes
I Adrados, J Larrasa-Alonso, A Galarreta, I López-Antona, C Menéndez, M Abad, J Gil, G Moreno-Bueno, I Palmero
Oncogene 2015
Links between cancer stem cells and epithelial– mesenchymal transition
Y Tang, S Wang, J Jiang, X Liang
OncoTargets and therapy 2015
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p
CG Towers, AL Guarnieri, DS Micalizzi, JC Harrell, AE Gillen, J Kim, CA Wang, MU Oliphant, DJ Drasin, MA Guney, P Kabos, CA Sartorius, AC Tan, CM Perou, JM Espinosa, HL Ford
Nature Communications 2015
Oncogenic roles of EMT-inducing transcription factors
A Puisieux, T Brabletz, J Caramel
Nature Cell Biology 2014
The PI3K/Akt signal hyperactivates Eya1 via the SUMOylation pathway
Y Sun, S Kaneko, XK Li, X Li
Oncogene 2014
SHOX2 Is a Direct miR-375 Target and a Novel Epithelial-to-Mesenchymal Transition Inducer in Breast Cancer Cells
S Hong, H Noh, Y Teng, J Shao, H Rehmani, HF Ding, Z Dong, SB Su, H Shi, J Kim, S Huang
Neoplasia (New York, N.Y.) 2014
Regulation of male sex determination: genital ridge formation and Sry activation in mice
SS Tanaka, R Nishinakamura
Cellular and Molecular Life Sciences 2014
DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
Q Chu, N Han, X Yuan, X Nie, H Wu, Y Chen, M Guo, S Yu, K Wu
Journal of Hematology & Oncology 2014
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer
AS Dhillon, E Tulchinsky
Oncogene 2014
The Canonical Wnt Signal Restricts the Glycogen Synthase Kinase 3/Fbw7-Dependent Ubiquitination and Degradation of Eya1 Phosphatase
Y Sun, X Li
Molecular and cellular biology 2014
Eya1 Interacts with Six2 and Myc to Regulate Expansion of the Nephron Progenitor Pool during Nephrogenesis
J Xu, EY Wong, C Cheng, J Li, MT Sharkar, CY Xu, B Chen, J Sun, D Jing, PX Xu
Developmental Cell 2014
MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1
JH O'Brien, L Hernandez-Lagunas, KB Artinger, HL Ford
Journal of cell science 2014
Epithelial-Mesenchymal Transition and Tumor Suppression Are Controlled by a Reciprocal Feedback Loop between ZEB1 and Grainyhead-like-2
B Cieply, J Farris, J Denvir, HL Ford, SM Frisch
Cancer research 2013
Regulatory networks defining EMT during cancer initiation and progression
BD Craene, G Berx
Nature Reviews Cancer 2013
Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells
Y Liu, H Li, J Feng, X Cui, W Huang, Y Li, F Su, Q Liu, J Zhu, X Lv, J Chen, D Huang, F Yu
PloS one 2013
Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression
Z Li, T Tian, F Lv, Y Chang, X Wang, L Zhang, X Li, L Li, W Ma, J Wu, M Zhang
PloS one 2013
Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome
AN Patrick, JH Cabrera, AL Smith, XS Chen, HL Ford, R Zhao
Nature Structural & Molecular Biology 2013
A novel pro-lymphangiogenic SIX1-VEGF-C pathway mediates metastasis in mouse models of breast cancer
Chu-An Wang, Paul Jedlicka, Aaron N. Patrick, Douglas Micalizzi, Kimberly C Lemmer, Erin Deitsch, Matias Casás-Selves, J. Chuck Harrell, Heide Ford
Journal of Clinical Investigation 2012
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
AL Smith, R Iwanaga, DJ Drasin, DS Micalizzi, RL Vartuli, AC Tan, HL Ford
Oncogene 2012
Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion
G Ferrari-Amorotti, V Fragliasso, R Esteki, Z Prudente, AR Soliera, S Cattelani, G Manzotti, G Grisendi, M Dominici, M Pieraccioli, G Raschellà, C Chiodoni, MP Colombo, B Calabretta
Cancer research 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer
L Qamar, E Deitsch, AN Patrick, MD Post, MA Spillman, R Iwanaga, A Thorburn, HL Ford, K Behbakht
Gynecologic Oncology 2012
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
LY Dimberg, CK Anderson, R Camidge, K Behbakht, A Thorburn, HL Ford
Oncogene 2012
The gain of function of p53 cancer mutant in promoting mammary tumorigenesis
X Lu, DP Liu, Y Xu
Oncogene 2012
Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells
F Fan, S Samuel, KW Evans, J Lu, L Xia, Y Zhou, E Sceusi, F Tozzi, XC Ye, SA Mani, LM Ellis
Cancer Medicine 2012
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis
CC Bitu, MF de Destro, M Carrera, SD da Silva, E Graner, LP Kowalski, FA Soares, RD Coletta
BMC Cancer 2012
Overexpression of Six1 leads to retardation of myogenic differentiation in C2C12 myoblasts
Z Li, D Deng, H Huang, L Tian, Z Chen, Y Zou, G Jin, J Wang, Q Zhang, L Wu, H Shen
Molecular Biology Reports 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
R Iwanaga, CA Wang, DS Micalizzi, JC Harrell, P Jedlicka, CA Sartorius, P Kabos, SM Farabaugh, AP Bradford, HL Ford
Breast Cancer Research 2012
Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity
AB Krueger, SJ Dehdashti, N Southall, JJ Marugan, M Ferrer, X Li, HL Ford, W Zheng, R Zhao
Journal of biomolecular screening 2012
Cancer stem cell subsets and their relationships
HG Liu, C Chen, H Yang, YF Pan, XH Zhang
Journal of Translational Medicine 2011
Cancer Stem Cells: Repair Gone Awry?
F Rangwala, A Omenetti, AM Diehl
Journal of Oncology 2011
Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity
DJ Drasin, TP Robin, HL Ford
Breast Cancer Research 2011
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression
CD May, N Sphyris, KW Evans, SJ Werden, W Guo, SA Mani
Breast Cancer Research 2011
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor
AS Beltran, AG Rivenbark, BT Richardson, X Yuan, H Quian, JP Hunt, E Zimmerman, LM Graves, P Blancafort
Breast Cancer Research 2011
Eya2 Is Required to Mediate the Pro-Metastatic Functions of Six1 Via the Induction of TGF-β Signaling, Epithelial-Mesenchymal Transition, and Cancer Stem Cell Properties
SM Farabaugh, DS Micalizzi, P Jedlicka, R Zhao, HL Ford
Oncogene 2011
Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis
Isabel Ben-Batalla, Samuel Seoane, Tomas Garcia-Caballero, Rosalia Gallego, Manuel Macia, Luis Gonzalez, Francisco Vizoso, Roman Perez-Fernandez
Journal of Clinical Investigation 2010
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression
DS Micalizzi, SM Farabaugh, HL Ford
Journal of Mammary Gland Biology and Neoplasia 2010
Nuclear factor- B signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells
N Gavert, A Ben-Shmuel, V Lemmon, T Brabletz, A Ben-Ze'ev
Journal of cell science 2010
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells
MA Taylor, JG Parvani, WP Schiemann
Journal of Mammary Gland Biology and Neoplasia 2010
Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells
G Ouyang, Z Wang, X Fang, J Liu, CJ Yang
Cellular and Molecular Life Sciences 2010
The Pathology of EMT in Mouse Mammary Tumorigenesis
RD Cardiff
Journal of Mammary Gland Biology and Neoplasia 2010
Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer
N Gavert, A Ben-Ze'ev
F1000 biology reports 2010
Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis
RD Coletta, EL McCoy, V Burns, K Kawakami, JL McManaman, JJ Wysolmerski, HL Ford
BMC Developmental Biology 2010
Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis
Derek Radisky
Journal of Clinical Investigation 2009
Interplay of retinal determination gene network with TGF-β signaling pathway in epithelial-mesenchymal transition
Yu Liu, Deguang Kong, Hua Wu, Xun Yuan, Hanxiao Xu, Cuntai Zhang, Gaosong Wu, Kongming Wu
Stem Cell Investigation
HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells
M Shah, R Cardenas, B Wang, J Persson, NP Mongan, A Grabowska, C Allegrucci
Molecular Cancer 2017
Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer
T Lerbs, S Bisht, S Schölch, M Pecqueux, G Kristiansen, M Schneider, BT Hofmann, T Welsch, C Reissfelder, NN Rahbari, J Fritzmann, P Brossart, J Weitz, G Feldmann, C Kahlert
BMC Cancer 2017
MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1
Q Zhu, H Li, Y Li, L Jiang
Human Cell 2017
SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer
AA Suen, WN Jefferson, CE Wood, E Padilla-Banks, VL Bae-Jump, CJ Williams
Molecular cancer research : MCR 2016
The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line
M Armat, TO Bakhshaiesh, M Sabzichi, D Shanehbandi, S Sharifi, O Molavi, J Mohammadian, MS Hejazi, N Samadi
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2015
CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
Li L, Liu C, Amato RJ, Chang JT, Du G, Li W
Oncotarget 2014
Regulation of mesenchymal phenotype by MicroRNAs in cancer.
Yan J, Gumireddy K, Li A, Huang Q
Current cancer drug targets 2013
Emerging Role of Mucins in Epithelial to Mesenchymal Transition
Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK
Current cancer drug targets 2013
Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth
DS Micalizzi, CA Wang, SM Farabaugh, WP Schiemann, HL Ford
Cancer research 2010

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
96 readers on Mendeley
See more details